智雲股份(300097.SZ):獲首份口罩生產設備訂單 合同總金額1060萬元
格隆匯2月14日丨智雲股份(300097.SZ)公佈,近日,公司全資子公司鑫三力與傑佰淨化簽訂了高速平面耳帶式口罩全自動機生產線、N95耳帶式口罩全自動機生產線、平面口罩後工序生產線、口罩耳帶電焊機的採購合同,均系鑫三力獲得的首份口罩生產設備的訂單。採購數量合計65套,合同總金額(含税)1060萬元,首批交貨日期2020年3月15日。
公司表示,切入口罩生產設備有利於公司進一步拓展醫療器材以及醫療設備相關的自動化設備市場,進一步優化公司的產品結構,符合公司多元化發展的戰略佈局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.